Actis acquires Rx Propellant
Actis, a global investor in sustainable infrastructure, has acquired Rx Propellant, a platform focused on providing real estate solutions (R&D labs and associated facilities) to tenants in the life sciences and related sectors in India. Rx Propellant focuses on the life sciences real estate sector and is currently involved in